1. Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis. Issue 4 (23rd April 2008) Authors: Dieguez-Gonzalez, R; Akar, S; Calaza, M; Perez-Pampin, E; Costas, J; Torres, M; Vicario, J L; Velloso, M L; Navarro, F; Narvaez, J; Joven, B; Herrero-Beaumont, G; Gonzalez-Alvaro, I; Fernandez-Gutierrez, B; de la Serna, A R; Carreño, L; Lopez-Longo, J; Caliz, R; Collado-Escobar, M D; Blanco, F J Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 4(2009) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0651 Should we reduce the dose of biological therapy to all patients with inflammatory arthritis achieving sustained therapeutic goal?. (15th June 2017) Authors: Gonzalez-Alvaro, I; Sánchez-Piedra, C; Almodovar, R; Bachiller, J; Balsa, A; Blasco, AJ; Caliz, R; Candelas, G; Fernández-Carballido, C; García-Aparicio, A; García-Magallόn, B; García-Vicuña, R; Gomez-Centeno, A; Ortiz, AM; Sanmartí, R; Sanz, J; Tejera, B; Notario, I; Soto, MJ; Plasencia, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗